Ursolic Acid Ameliorates the Injury of H9c2 Cells Caused by Hypoxia and Reoxygenation Through Mediating CXCL2/NF-κB Pathway

被引:4
|
作者
Bian, Zhongrui [1 ]
Xu, Fei [1 ]
Liu, Hui [1 ]
Du, Yimeng [1 ]
机构
[1] Shandong Univ, Dept Cardiol, Hosp 2, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China
关键词
HY-18739; Inflammation; Oxidative stress; siRNA; NF-KAPPA-B; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; PROTECTS; INFLAMMATION; ACTIVATION; EXPRESSION; CHEMOKINES; CXCL2;
D O I
10.1536/ihj.21-807
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ursolic acid (UA) has been reported to possess several biological benefits, such as anti-cancer, anti-inflammation, antibacterial, and neuroprotective functions. This study detects the function and molecular mecha-nism of UA in H9c2 cells under hypoxia and reoxygenation (H/R) conditions. Under H/R stimulation, the effects of UA on H9c2 cells were examined using ELISA and western blot assays. The Comparative Toxicogenomics Database was employed to analyze the target molecule of UA. Small interfering RNA was used to knock down CXCL2 expression, further exploring the function of CXCL2 in H/R-induced H9c2 cells. The genes related to the nuclear factor-kappa B (NF--KB) pathway were assessed using western blot analysis. Significant effects of UA on H/R-induced H9c2 cell damage were observed, accompanied by reduced inflammation and oxidative stress injury. Additionally, the increased level of CXCL2 in H/R-induced H9c2 cells was reduced after UA stimulation. Moreover, CXCL2 knockdown strengthened the beneficial effect of UA on H/R-induced H9c2 cells. HY-18739, an activator of the NF-kappa B pathway, can increase CXCL2 expression. Moreover, the increased levels of p-P65 NF-kappa B and p-I-KB alpha in H/R-induced H9c2 cells were remarkably attenuated by UA treatment. In summary, the results indicated that UA may alleviate the damage of H9c2 cells by targeting the CXCL2/NF-kappa B pathway under H/R conditions.
引用
收藏
页码:755 / 762
页数:8
相关论文
共 50 条
  • [2] Lidocaine protects H9c2 cells from hypoxia-induced injury through regulation of the MAPK/ERK/NF-κB signaling pathway
    Jin, Haibin
    Yu, Jin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 4125 - 4131
  • [3] Schizandrin B attenuates hypoxia/reoxygenation injury in H9c2 cells by activating the AMPK/Nrf2 signaling pathway
    Zhao, Bo
    Li, Guang-Ping
    Peng, Jian-Jun
    Ren, Li-Hui
    Lei, Li-Cheng
    Ye, Hui-Ming
    Wang, Zuo-Yan
    Zhao, Sheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (03)
  • [4] Cardioprotective potential of Ligusticum sinense on hypoxia/reoxygenation injury in H9c2 cells
    Nusuetrong, P.
    Gerdprasert, O.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S203 - S203
  • [5] Ferulic Acid Attenuates Hypoxia/Reoxygenation Injury by Suppressing Mitophagy Through the PINK1/Parkin Signaling Pathway in H9c2 Cells
    Luo, Chenxi
    Zhang, Yehao
    Guo, Hao
    Han, Xiao
    Ren, Junguo
    Liu, Jianxun
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [6] Eleutheroside E decreases oxidative stress and NF-κB activation and reprograms the metabolic response against hypoxia-reoxygenation injury in H9c2 cells
    Wang, Shanyue
    Yang, Xuming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 84
  • [7] TRIM38 protects H9c2 cells from hypoxia/reoxygenation injury via the TRAF6/TAK1/NF-κB signalling pathway
    Lu, Zhengri
    Deng, Mengen
    Ma, Genshan
    Chen, Lijuan
    PEERJ, 2022, 10
  • [8] Plantamajoside protects H9c2 cells against hypoxia/reoxygenation-induced injury through regulating the akt/Nrf2/HO-1 and NF-κB signaling pathways
    Zeng, Guangwei
    An, Huixian
    Fang, Dong
    Wang, Wei
    Han, Yang
    Lian, Cheng
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2022, 42 (02) : 125 - 132
  • [9] Effects of red blood cell supernatants on hypoxia/reoxygenation injury in H9C2 cells
    Fan, Fengyan
    Sun, Liping
    Zhang, Dongqing
    Zhu, Liguo
    Wang, Shuying
    Wang, Deqing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3612 - 3619
  • [10] CIRBP protects H9C2 cells against myocardial ischemia through inhibition of NF-κB pathway df
    Long, T. Y.
    Jing, R.
    Kuang, F.
    Huang, L.
    Qian, Z. X.
    Yang, T. L.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2017, 50 (04)